<PAGE>1
As filed with the Securities and Exchange Commission on January 15, 1997
Registration No. 33-57616
- ------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------
Post-effective
Amendment No. 1
to
Form S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-----------
PHARMAKINETICS LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Maryland 52-1067519
(State of Incorporation) (I.R.S. Employer Identification No.)
302 West Fayette Street
Baltimore, Maryland 21201
(410) 385-4500
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
James K. Leslie, President and Chief Executive Officer
PharmaKinetics Laboratories, Inc.
Incentive Stock Option Plan
302 West Fayette Street
Baltimore, Maryland 21201
(410) 385-4500
(Name, address, including zip code, and telephone number, including
area code, of agent for service)
<PAGE>2
The Registrant hereby amends this Registration Statement on Form
S-8 (No. 33-57616) to remove from registration 828,063 shares of
PharmaKinetics Laboratories, Inc. Common Stock which remain unissued
after the expiration in September, 1995 of the Incentive Stock Option
Plan described in said Registration Statement.
-----------
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as
amended, the Registrant has duly caused this Post-effective Amendment
No. 1 to Registration Statement on Form S-8 (No. 33-57616) to be
signed on its behalf by the undersigned, thereunto duly authorized, in
Baltimore, Maryland on January 15, 1997.
PHARMAKINETICS LABORATORIES, INC.
By: /s/ James K. Leslie
-----------------------------
James K. Leslie
President and
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of
1934, this Post-effective Amendment No. 1 to Registration Statement on
Form S-8 (No. 33-57616) has been signed below by the following persons
in the capacities and on the dates indicated.
/s/ James K. Leslie January 15, 1997
- -------------------
James K. Leslie
President and Chief Executive
Officer, Director
(Principal Executive Officer)
/s/ Taryn L. Kunkel January 15, 1997
- -------------------
Taryn L. Kunkel
Vice President
(Principal Financial and
Accounting Officer)
/s/ Roger C. Thies January 15, 1997
- -------------------
Roger C. Thies
Director
- -------------------
Thomas F. Kearns, Jr.
Director
